Biotech Stocks to Buy: Up to 26.54% Return in 7 Days

Package Name: Industry Package - Biotech Stocks
Forecast Length: 1 Week (7/3/15 – 7/12/15)
I Know First Average: 3.85%

Read The Full Forecast

Biotech Stocks to Buy

How to interpret this diagram:

Xoma Stock Analysis: Why XOMA Is Such a Risky Investment (XOMA)

Xoma Stock Analysis: Summary

  • XOMA’s co-development of Gevokizumab with Servier is currently on track.xoma stock analysis
  • Highly leveraged and dependant on one drugs success makes this investment similar to a binary option flip.
  • Algorithmic analysis is very bullish based on recent price movement and money flow analysis.
XOMA Corporation (NASDAQ: XOMA) is a company which researches antibody based therapeutics in the United States, Europe, and Asia Pacific.

Algorithmic Analysis

The I Know First’s market screening algorithm supports the opinion that XOMA’s stock will likely increase in price over the next 3 months and 1 year periods. According to the forecast the 3rd best small cap opportunity is XOMA, with a strong signal (middle number) of 181.10 in the 3 month horizon and 295.78 in the 1 year.

Read The Full Article